NEUROD6
gene geneOn this page
Also known as Atoh2NEX1MMath-2bHLHa2Nex1
Summary
NEUROD6 (neuronal differentiation 6, HGNC:13804) is a protein-coding gene on chromosome 7p14.3, encoding Neurogenic differentiation factor 6 (Q96NK8). Activates E box-dependent transcription in collaboration with TCF3/E47.
This gene is a member of the NEUROD family of basic helix-loop-helix transcription factors. The encoded protein may be involved in the development and differentiation of the nervous system.
Source: NCBI Gene 63974 — RefSeq curated summary.
At a glance
- GWAS associations: 3
- Clinical variants (ClinVar): 29 total — 1 pathogenic
- Transcription factor: yes — 11 downstream targets (CollecTRI)
- MANE Select transcript:
NM_022728
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:13804 |
| Approved symbol | NEUROD6 |
| Name | neuronal differentiation 6 |
| Location | 7p14.3 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | Atoh2, NEX1M, Math-2, bHLHa2, Nex1 |
| Ensembl gene | ENSG00000164600 |
| Ensembl biotype | protein_coding |
| OMIM | 611513 |
| Entrez | 63974 |
Gene structure
Transcript identifiers
Ensembl transcripts: 1 — 1 protein_coding
ENST00000297142
RefSeq mRNA: 1 — MANE Select: NM_022728
NM_022728
CCDS: CCDS5434
Canonical transcript exons
ENST00000297142 — 2 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001085769 | 31337465 | 31339289 |
| ENSE00001085770 | 31340593 | 31340726 |
Expression profiles
Bgee: expression breadth broad, 57 present calls, max score 99.73.
FANTOM5 (CAGE): breadth tissue_specific, TPM avg 4.8872 / max 2124.3349, expressed in 94 samples.
FANTOM5 promoters (5 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 83463 | 4.2713 | 87 |
| 83464 | 0.2252 | 52 |
| 204404 | 0.1555 | 31 |
| 83466 | 0.1415 | 45 |
| 83465 | 0.0936 | 27 |
Top tissues by expression
262 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| cortical plate | UBERON:0005343 | 99.73 | gold quality |
| ganglionic eminence | UBERON:0004023 | 99.44 | gold quality |
| Brodmann (1909) area 46 | UBERON:0006483 | 95.24 | gold quality |
| orbitofrontal cortex | UBERON:0004167 | 94.22 | gold quality |
| CA1 field of hippocampus | UBERON:0003881 | 93.08 | gold quality |
| prefrontal cortex | UBERON:0000451 | 89.79 | gold quality |
| dorsolateral prefrontal cortex | UBERON:0009834 | 89.77 | gold quality |
| Ammon’s horn | UBERON:0001954 | 88.76 | gold quality |
| Brodmann (1909) area 9 | UBERON:0013540 | 88.63 | gold quality |
| cerebral cortex | UBERON:0000956 | 88.48 | gold quality |
| frontal cortex | UBERON:0001870 | 88.45 | gold quality |
| frontal lobe | UBERON:0016525 | 88.45 | gold quality |
| superior frontal gyrus | UBERON:0002661 | 88.26 | gold quality |
| anterior cingulate cortex | UBERON:0009835 | 88.11 | gold quality |
| cingulate cortex | UBERON:0003027 | 88.06 | gold quality |
| neocortex | UBERON:0001950 | 88.05 | gold quality |
| right frontal lobe | UBERON:0002810 | 87.00 | gold quality |
| entorhinal cortex | UBERON:0002728 | 86.72 | gold quality |
| postcentral gyrus | UBERON:0002581 | 86.66 | gold quality |
| ventricular zone | UBERON:0003053 | 83.44 | gold quality |
| parietal lobe | UBERON:0001872 | 83.36 | gold quality |
| embryo | UBERON:0000922 | 80.33 | gold quality |
| temporal lobe | UBERON:0001871 | 80.10 | gold quality |
| middle temporal gyrus | UBERON:0002771 | 79.10 | gold quality |
| Brodmann (1909) area 23 | UBERON:0013554 | 78.18 | gold quality |
| amygdala | UBERON:0001876 | 77.38 | gold quality |
| primary visual cortex | UBERON:0002436 | 75.16 | gold quality |
| endothelial cell | CL:0000115 | 74.93 | gold quality |
| cerebellar vermis | UBERON:0004720 | 74.81 | silver quality |
| diaphragm | UBERON:0001103 | 74.14 | gold quality |
Single-cell (SCXA)
Detected in 5 experiment(s), a significant marker in 4.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-MTAB-10485 | yes | 3812.51 |
| E-HCAD-5 | yes | 2654.39 |
| E-MTAB-8894 | yes | 1777.18 |
| E-GEOD-75140 | yes | 1714.67 |
| E-ANND-3 | no | 1.97 |
Regulation
Is transcription factor: yes
Downstream targets (CollecTRI)
11 targets.
| Target | Regulation |
|---|---|
| CDKN1A | Activation |
| GAL | Unknown |
| GAP43 | Activation |
| KIF5B | Unknown |
| ME1 | Activation |
| NEUROD1 | |
| NGF | |
| PCSK6 | |
| PDYN | Unknown |
| SRGN | |
| YBX1 |
Upstream regulators (CollecTRI, top): CEBPB, CEBPG
miRNA regulators (miRDB)
97 targeting NEUROD6, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-4795-3P | 100.00 | 74.62 | 4024 |
| HSA-MIR-1277-5P | 100.00 | 73.95 | 5056 |
| HSA-LET-7A-3P | 100.00 | 74.03 | 3932 |
| HSA-LET-7B-3P | 100.00 | 74.08 | 3913 |
| HSA-LET-7F-1-3P | 100.00 | 74.02 | 3928 |
| HSA-MIR-98-3P | 100.00 | 74.08 | 3907 |
| HSA-MIR-6851-5P | 100.00 | 65.63 | 1294 |
| HSA-MIR-3689D | 100.00 | 66.14 | 1181 |
| HSA-MIR-126-5P | 100.00 | 72.71 | 3180 |
| HSA-MIR-340-5P | 100.00 | 72.50 | 4437 |
| HSA-MIR-30A-5P | 100.00 | 76.31 | 3233 |
| HSA-MIR-30B-5P | 100.00 | 76.29 | 3248 |
| HSA-MIR-30C-5P | 100.00 | 76.29 | 3248 |
| HSA-MIR-30D-5P | 100.00 | 76.32 | 3233 |
| HSA-MIR-30E-5P | 100.00 | 76.32 | 3242 |
| HSA-MIR-4282 | 99.99 | 75.36 | 6408 |
| HSA-MIR-150-5P | 99.99 | 66.69 | 1976 |
| HSA-MIR-548C-3P | 99.99 | 74.01 | 7587 |
| HSA-MIR-4789-5P | 99.98 | 70.76 | 2721 |
| HSA-LET-7F-2-3P | 99.98 | 70.98 | 2588 |
| HSA-MIR-1185-1-3P | 99.98 | 71.04 | 2593 |
| HSA-MIR-1185-2-3P | 99.98 | 71.04 | 2593 |
| HSA-MIR-12136 | 99.98 | 72.81 | 5713 |
| HSA-MIR-27A-3P | 99.98 | 72.13 | 2955 |
| HSA-MIR-27B-3P | 99.98 | 72.13 | 2955 |
| HSA-MIR-9985 | 99.98 | 72.11 | 2939 |
| HSA-MIR-512-3P | 99.97 | 67.35 | 1049 |
| HSA-MIR-1229-3P | 99.97 | 66.49 | 906 |
| HSA-MIR-3148 | 99.97 | 75.06 | 6478 |
| HSA-MIR-5688 | 99.96 | 73.23 | 4504 |
Literature-anchored findings (GeneRIF, showing 3)
- cloning and some features of a novel human gene, MATH2, which encodes a protein of 337 amino acid residues with a basic helix loop helix domain and exhibits 98% similarity to mouse Math2 (PMID:12357074)
- NeuroD6 serves as a possible biomarker for Alzheimer disease brains. (PMID:25548427)
- single nucleotide polymorphisms in either the region of NEUROD6 or SNAP25 were significantly associated with Alzheimer’s Disease, in APOE4+ females and APOE4+ males, respectively. (PMID:26395074)
Cross-species orthologs
9 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | neurod6b | ENSDARG00000020794 |
| danio_rerio | neurod6a | ENSDARG00000040008 |
| mus_musculus | Neurod6 | ENSMUSG00000037984 |
| rattus_norvegicus | Neurod6 | ENSRNOG00000026055 |
| drosophila_melanogaster | amos | FBGN0003270 |
| drosophila_melanogaster | ato | FBGN0010433 |
| drosophila_melanogaster | tap | FBGN0015550 |
| caenorhabditis_elegans | WBGENE00003018 | |
| caenorhabditis_elegans | WBGENE00003595 |
Paralogs (15): NEUROG3 (ENSG00000122859), NEUROD4 (ENSG00000123307), BHLHE23 (ENSG00000125533), NEUROD1 (ENSG00000162992), ATOH8 (ENSG00000168874), NEUROD2 (ENSG00000171532), ATOH1 (ENSG00000172238), OLIG3 (ENSG00000177468), NEUROG2 (ENSG00000178403), ATOH7 (ENSG00000179774), BHLHA15 (ENSG00000180535), BHLHE22 (ENSG00000180828), NEUROG1 (ENSG00000181965), OLIG1 (ENSG00000184221), OLIG2 (ENSG00000205927)
Protein
Protein identifiers
Neurogenic differentiation factor 6 — Q96NK8 (reviewed: Q96NK8)
Alternative names: Class A basic helix-loop-helix protein 2, Protein atonal homolog 2
All UniProt accessions (2): A0A090N7T3, Q96NK8
UniProt curated annotations — full annotation on UniProt →
Function. Activates E box-dependent transcription in collaboration with TCF3/E47. May be a trans-acting factor involved in the development and maintenance of the mammalian nervous system. Transactivates the promoter of its own gene.
Subunit / interactions. Efficient DNA binding requires dimerization with another bHLH protein.
Subcellular location. Nucleus.
RefSeq proteins (1): NP_073565* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR011598 | bHLH_dom | Domain |
| IPR016637 | TF_bHLH_NeuroD | Family |
| IPR022575 | NeuroD_DUF | Domain |
| IPR036638 | HLH_DNA-bd_sf | Homologous_superfamily |
| IPR050359 | bHLH_transcription_factors | Family |
Pfam: PF00010, PF12533
UniProt features (5 total): chain 1, domain 1, region of interest 1, short sequence motif 1, compositionally biased region 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q96NK8-F1 | 62.31 | 0.25 |
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 166 (showing top):
ATF_B, RNGTGGGC_UNKNOWN, GOBP_DENTATE_GYRUS_DEVELOPMENT, GCANCTGNY_MYOD_Q6, GOBP_NEUROGENESIS, CREBP1_Q2, TAL1ALPHAE47_01, LHX3_01, CTATGCA_MIR153, GTACAGG_MIR486, GOBP_FOREBRAIN_DEVELOPMENT, MODULE_313, NKX61_01, CREB_Q4, EVI1_05
GO Biological Process (7): sensory organ development (GO:0007423), dentate gyrus development (GO:0021542), positive regulation of transcription by RNA polymerase II (GO:0045944), axon development (GO:0061564), regulation of DNA-templated transcription (GO:0006355), nervous system development (GO:0007399), cell differentiation (GO:0030154)
GO Molecular Function (7): DNA-binding transcription factor activity, RNA polymerase II-specific (GO:0000981), DNA-binding transcription activator activity, RNA polymerase II-specific (GO:0001228), protein dimerization activity (GO:0046983), E-box binding (GO:0070888), RNA polymerase II cis-regulatory region sequence-specific DNA binding (GO:0000978), DNA binding (GO:0003677), sequence-specific double-stranded DNA binding (GO:1990837)
GO Cellular Component (2): chromatin (GO:0000785), nucleus (GO:0005634)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| RNA polymerase II transcription regulatory region sequence-specific DNA binding | 3 |
| regulation of transcription by RNA polymerase II | 2 |
| animal organ development | 1 |
| hippocampus development | 1 |
| anatomical structure development | 1 |
| transcription by RNA polymerase II | 1 |
| positive regulation of DNA-templated transcription | 1 |
| neuron projection development | 1 |
| DNA-templated transcription | 1 |
| regulation of gene expression | 1 |
| regulation of RNA biosynthetic process | 1 |
| system development | 1 |
| cellular developmental process | 1 |
| chromatin | 1 |
| DNA-binding transcription factor activity | 1 |
| DNA-binding transcription factor activity, RNA polymerase II-specific | 1 |
| DNA-binding transcription activator activity | 1 |
| positive regulation of transcription by RNA polymerase II | 1 |
| protein binding | 1 |
| RNA polymerase II cis-regulatory region sequence-specific DNA binding | 1 |
| cis-regulatory region sequence-specific DNA binding | 1 |
| nucleic acid binding | 1 |
| double-stranded DNA binding | 1 |
| sequence-specific DNA binding | 1 |
| chromosome | 1 |
| cellular anatomical structure | 1 |
| intracellular membrane-bounded organelle | 1 |
Protein interactions and networks
STRING
2144 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| NEUROD6 | TBR1 | Q16650 | 773 |
| NEUROD6 | EMX1 | Q04741 | 714 |
| NEUROD6 | FEZF2 | Q8TBJ5 | 713 |
| NEUROD6 | SATB2 | Q9UPW6 | 712 |
| NEUROD6 | FOXG1 | P55315 | 672 |
| NEUROD6 | ASCL1 | P50553 | 496 |
| NEUROD6 | EOMES | O95936 | 489 |
| NEUROD6 | POU3F1 | Q03052 | 475 |
| NEUROD6 | PAX6 | P26367 | 467 |
| NEUROD6 | DLX1 | P56177 | 467 |
| NEUROD6 | SNCA | P37840 | 464 |
| NEUROD6 | CDKN1C | P49918 | 461 |
| NEUROD6 | BCL11B | Q9C0K0 | 461 |
| NEUROD6 | GLS | O94925 | 449 |
| NEUROD6 | BDNF | P23560 | 442 |
| NEUROD6 | GAD1 | Q99259 | 442 |
IntAct
7 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| NEUROD6 | KTN1 | psi-mi:“MI:0915”(physical association) | 0.400 |
| NEUROD6 | RANGAP1 | psi-mi:“MI:0915”(physical association) | 0.400 |
| NEUROD6 | psi-mi:“MI:0915”(physical association) | 0.370 | |
| TNIK | NEUROD6 | psi-mi:“MI:0915”(physical association) | 0.000 |
| DISC1 | NEUROD6 | psi-mi:“MI:0915”(physical association) | 0.000 |
| DSCR9 | NEUROD6 | psi-mi:“MI:0915”(physical association) | 0.000 |
BioGRID (4): NEUROD6 (Affinity Capture-Western), NEUROD6 (Proximity Label-MS), NEUROD6 (Proximity Label-MS), NEUROD6 (Two-hybrid)
ESM2 similar proteins: A0A140LFM6, B0FZN7, B0FZN8, B0FZN9, B0FZP0, B0FZP1, B0FZP2, B0FZP3, B0S6S9, O08750, O60381, P01105, P10157, P18755, P19102, P32314, Q08D88, Q08DI0, Q16649, Q1LXZ9, Q2KJ34, Q3UPW2, Q3YC04, Q4JM28, Q4R5G6, Q4V7E1, Q5DTV4, Q5FW38, Q5HYM0, Q5R7I3, Q5ZJK5, Q62661, Q66J36, Q66J77, Q68EL6, Q6NRK3, Q6NYU3, Q8AYI2, Q8C8Y5, Q8K402
Diamond homologs: A6NI15, O08574, O09105, O42202, P41894, P46581, P48986, P79765, P79766, P79920, P97309, Q08DI0, Q0VG99, Q13562, Q28C89, Q4R5G6, Q60430, Q60867, Q64289, Q90ZL1, Q91616, Q96NK8, Q9BRJ9, Q9DEQ9, Q9HD90, Q9JK54, Q9W690, Q9W6C7, Q9Y4Z2, A8E5T6, B6VQA1, O09029, O13125, O13126, O16867, O35437, O42606, O43680, O45489, O57598
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
29 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 1 |
| Likely pathogenic | 0 |
| Uncertain significance | 28 |
| Likely benign | 0 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (1)
| Variant ID | HGVS | Classification |
|---|---|---|
| 563420 | GRCh37/hg19 7p14.3-13(chr7:30463886-43470805)x3 | Pathogenic |
SpliceAI
147 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 7:31339287:TACC:T | acceptor_loss | 0.8900 |
| 7:31339288:ACCT:A | acceptor_loss | 0.8900 |
| 7:31339290:CTGAA:C | acceptor_loss | 0.8900 |
| 7:31339291:T:A | acceptor_loss | 0.8900 |
| 7:31339169:GCTTC:G | acceptor_gain | 0.8700 |
| 7:31339292:G:C | acceptor_loss | 0.8600 |
| 7:31339286:TTAC:T | acceptor_gain | 0.8500 |
| 7:31339293:AAAAA:A | acceptor_loss | 0.8300 |
| 7:31339294:AAAAA:A | acceptor_loss | 0.8300 |
| 7:31339244:ACTC:A | acceptor_gain | 0.8100 |
| 7:31339243:GACTC:G | acceptor_gain | 0.8000 |
| 7:31339245:CTCAT:C | acceptor_gain | 0.8000 |
| 7:31339233:C:A | acceptor_gain | 0.7800 |
| 7:31339242:AGACT:A | acceptor_gain | 0.7800 |
| 7:31339246:T:A | acceptor_gain | 0.7800 |
| 7:31340587:TATTA:T | donor_loss | 0.7600 |
| 7:31340588:ATTAC:A | donor_loss | 0.7600 |
| 7:31340589:TTACC:T | donor_loss | 0.7600 |
| 7:31340590:TA:T | donor_loss | 0.7600 |
| 7:31340591:ACC:A | donor_loss | 0.7600 |
| 7:31340592:C:T | donor_loss | 0.7600 |
| 7:31340593:C:A | donor_loss | 0.7500 |
| 7:31340638:T:TA | donor_gain | 0.7500 |
| 7:31339162:C:A | acceptor_gain | 0.7400 |
| 7:31339168:GGCTT:G | acceptor_gain | 0.7400 |
| 7:31339235:T:TC | acceptor_gain | 0.7400 |
| 7:31340043:T:C | donor_gain | 0.7400 |
| 7:31340586:ATATT:A | donor_loss | 0.7300 |
| 7:31340082:CTG:C | donor_gain | 0.7200 |
| 7:31339235:T:A | acceptor_gain | 0.7000 |
AlphaMissense
2236 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 7:31338742:A:C | L176W | 1.000 |
| 7:31338742:A:G | L176S | 1.000 |
| 7:31338744:G:C | N175K | 1.000 |
| 7:31338744:G:T | N175K | 1.000 |
| 7:31338751:G:A | T173I | 1.000 |
| 7:31338760:G:A | S170F | 1.000 |
| 7:31338760:G:T | S170Y | 1.000 |
| 7:31338763:A:G | L169P | 1.000 |
| 7:31338763:A:T | L169H | 1.000 |
| 7:31338771:G:C | C166W | 1.000 |
| 7:31338772:C:T | C166Y | 1.000 |
| 7:31338775:A:G | L165S | 1.000 |
| 7:31338784:A:T | V162D | 1.000 |
| 7:31338820:A:G | L150P | 1.000 |
| 7:31338830:A:G | S147P | 1.000 |
| 7:31338832:A:G | L146P | 1.000 |
| 7:31338832:A:T | L146H | 1.000 |
| 7:31338841:A:T | I143N | 1.000 |
| 7:31338845:A:G | Y142H | 1.000 |
| 7:31338846:G:C | N141K | 1.000 |
| 7:31338846:G:T | N141K | 1.000 |
| 7:31338853:G:T | A139D | 1.000 |
| 7:31338854:C:G | A139P | 1.000 |
| 7:31338856:A:G | L138P | 1.000 |
| 7:31338856:A:T | L138Q | 1.000 |
| 7:31338859:C:G | R137P | 1.000 |
| 7:31338861:T:A | L136F | 1.000 |
| 7:31338861:T:G | L136F | 1.000 |
| 7:31338862:A:G | L136S | 1.000 |
| 7:31338868:T:A | E134V | 1.000 |
dbSNP variants (sampled 300 via entrez): RS1001840393 (7:31339171 T>C), RS1001905328 (7:31338615 A>G,T), RS1001908402 (7:31338187 A>G,T), RS1001962404 (7:31338682 G>T), RS1002748450 (7:31342246 A>G), RS1003645866 (7:31342572 G>C), RS1003857835 (7:31342116 G>A), RS1003889071 (7:31341825 T>C), RS1005093330 (7:31340913 A>C), RS1005733216 (7:31337493 T>A), RS1005764195 (7:31337137 T>G), RS1006066665 (7:31339787 T>A), RS1006185216 (7:31340708 T>A), RS1007761943 (7:31339945 G>A), RS1008038320 (7:31339714 A>C,G)
Disease associations
OMIM: gene MIM:611513 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
3 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST002688_2 | Very long-chain saturated fatty acid levels (fatty acid 22:0) | 5.000000e-06 |
| GCST006137_13 | Serum folate levels | 2.000000e-07 |
| GCST90000047_136 | Age at first sexual intercourse | 3.000000e-13 |
EFO canonical traits (2, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0006796 | very long-chain saturated fatty acid measurement |
| EFO:0009749 | age at first sexual intercourse measurement |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
6 total (human), top 6 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| methylmercuric chloride | increases expression | 1 |
| 2-palmitoylglycerol | increases expression | 1 |
| entinostat | decreases expression | 1 |
| Benzo(a)pyrene | affects methylation | 1 |
| Cyclosporine | increases methylation | 1 |
| Aflatoxin B1 | decreases methylation | 1 |
Cellosaurus cell lines
3 cell lines: 3 embryonic stem cell
First 10 cell lines (id-ordered, not curated):
| Cellosaurus | Name | Category | Sex |
|---|---|---|---|
| CVCL_A4K9 | SEES3-1V human NEUROD6, clone1 | Embryonic stem cell | Male |
| CVCL_A4L0 | SEES3-1V human NEUROD6, clone2 | Embryonic stem cell | Male |
| CVCL_A4L1 | SEES3-1V human NEUROD6, clone3 | Embryonic stem cell | Male |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.